Literature DB >> 15485587

Inflammation, insulin resistance, and obesity.

Patrizia Ferroni1, Stefani Basili, Angela Falco, Giovanni Davì.   

Abstract

Obesity, in particular visceral obesity, has strong associations with cardiovascular disease and is related to many factors that are constituents of the metabolic syndrome. Increasing evidence suggests that features of the metabolic syndrome, including visceral obesity, are associated with a low-grade inflammatory state. Indeed, visceral fat is a source of several molecules, such as leptin, adiponectin, tumor necrosis factor-alpha, and interleukin 6, that are collectively called adipokines. All of them may induce a proinflammatory state and oxidative damage, leading to initiation and progression of atherosclerosis. Reduced-energy diets might represent an effective and healthful approach for long-term weight loss in patients with metabolic syndrome by reducing the underlying inflammatory condition.

Entities:  

Mesh:

Year:  2004        PMID: 15485587     DOI: 10.1007/s11883-004-0082-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  49 in total

1.  Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study.

Authors:  John F Keaney; Martin G Larson; Ramachandran S Vasan; Peter W F Wilson; Izabella Lipinska; Diane Corey; Joseph M Massaro; Patrice Sutherland; Joseph A Vita; Emelia J Benjamin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

Review 2.  American College of Endocrinology position statement on the insulin resistance syndrome.

Authors:  Daniel Einhorn; Gerald M Reaven; Rhoda H Cobin; Earl Ford; Om P Ganda; Yehuda Handelsman; Richard Hellman; Paul S Jellinger; David Kendall; Ronald M Krauss; Naomi D Neufeld; Steven M Petak; Helena W Rodbard; John A Seibel; Donald A Smith; Peter W F Wilson
Journal:  Endocr Pract       Date:  2003 May-Jun       Impact factor: 3.443

3.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

4.  Implications of childhood obesity for adult health: findings from thousand families cohort study.

Authors:  C M Wright; L Parker; D Lamont; A W Craft
Journal:  BMJ       Date:  2001-12-01

5.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

6.  Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

Authors:  V Mohamed-Ali; S Goodrick; A Rawesh; D R Katz; J M Miles; J S Yudkin; S Klein; S W Coppack
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss.

Authors:  P Dandona; R Weinstock; K Thusu; E Abdel-Rahman; A Aljada; T Wadden
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

Review 8.  Inflammatory pathways and insulin action.

Authors:  G S Hotamisligil
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

Review 10.  The current biology of resistin.

Authors:  Claire M Steppan; Mitchell A Lazar
Journal:  J Intern Med       Date:  2004-04       Impact factor: 8.989

View more
  24 in total

1.  HIV and general cardiovascular risk.

Authors:  Bernadette Capili; Joyce K Anastasi; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2011-02-01       Impact factor: 1.354

2.  A Mediterranean dietary intervention in persons at high risk of colon cancer: recruitment and retention to an intensive study requiring biopsies.

Authors:  Zora Djuric; Mack T Ruffin; Mary E Rapai; Maria L Cornellier; Jianwei Ren; Thomas G Ferreri; Leah M Askew; Ananda Sen; Dean E Brenner; D Kim Turgeon
Journal:  Contemp Clin Trials       Date:  2012-05-26       Impact factor: 2.226

Review 3.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 4.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 5.  Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.

Authors:  D S Bond; J Roth; J M Nash; R R Wing
Journal:  Obes Rev       Date:  2011-05       Impact factor: 9.213

Review 6.  Toll-Like Receptor Function in Acute Wounds.

Authors:  Lin Chen; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

7.  Resistin increases the expression of NOD2 in mouse monocytes.

Authors:  Yi Ren; Taomei Wan; Zhicai Zuo; Hengmin Cui; Xi Peng; Jing Fang; Junliang Deng; Yanchun Hu; Shuming Yu; Liuhong Shen; Xiaoping Ma; Ya Wang; Zhihua Ren
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

8.  The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells.

Authors:  Bangning Yu; Carla Cook; Nalini Santanam
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

Review 9.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

10.  Obesity is associated with atypia in breast ductal lavage of women with proliferative breast disease.

Authors:  Zora Djuric; Ann Edwards; Shashi Madan; Linda Darga; Jianwei Ren; Cassann Blake; Mathew Koletsky; Lance K Heilbrun
Journal:  Cancer Epidemiol       Date:  2009-07-28       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.